Definiens

January 3, 2011 — Royal Philips Electronics and Definiens, a health image intelligence company, have signed a cooperation agreement to jointly develop a digital pathology system to support clinical diagnosis of several types of cancer, beginning with breast cancer.

Lymph nodes are a primary site of metastatic spread for almost all malignant tumors. Tracking changes to lymph node burden and lymph node staging has become increasingly important in diagnostics, as evidenced by the recent revision of RECIST criteria in early 2009. Clinicians recognize that lymph node staging is central to cancer patients’ treatment course and care management.

May 20, 2009 – Definiens, an image software company, and Moffitt Cancer Center will utilize Definiens technology in the analysis of lung cancer CT images for the purpose of developing more accurate prognosis and prediction models for response to specific lung cancer therapies.

October 30, 2008 – Definiens is developing computer-aided detection (CAD) applications for the 3D and 4D medical imaging field, Definiens LymphExpertT, designed to help radiologists rapidly and accurately identify and track lesions of interest, facilitating earlier detection and personalized treatments.